| Analysis | Metabolite Name | Measured Value | Units | diabetes | time of day |
|---|---|---|---|---|---|
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5935 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6173 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6406 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.7836 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.792 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.8596 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0457 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.2144 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.294 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3184 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3713 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.557 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.5978 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.7404 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.9546 | VolNormImp Area counts | db/db | ZT5 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|